Form 8-K · Current report

Dexcom 8-K, filed Sep 14, 2026

Filed
CIK
0001093557
Accession no.
0001093557-26-000175
AI-generated summary

Summary

DexCom, Inc. appointed Jereme Sylvain, its EVP and Chief Financial Officer, to also serve as Chief Operating Officer, effective September 14, 2026; he will oversee Dexcom's global operations and quality teams. His offer letter sets an annual base salary of $767,000 and a target bonus of 75% of base salary.

Key points

  • Dexcom's board appointed Jereme Sylvain to EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.
  • Sylvain joined Dexcom in 2018 and has been EVP and Chief Financial Officer since 2021.
  • The offer letter provides a $767,000 annual base salary and an annual target bonus of 75% of base salary.
  • Sylvain remains eligible for annual equity awards under Dexcom's Amended and Restated 2015 Equity Incentive Plan and participation in its Amended and Restated Severance & Change in Control Plan as an executive officer.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 7.01Regulation FD Disclosure
  • 9.01Financial Statements and Exhibits

From the filing

ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On September 10, 2026, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom” or the “Company”) appointed Jereme Sylvain, the Company’s EVP, Chief Financial Officer, to the role of EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026. In connection with Mr. Sylvain’s promotion, on September 11, 2026, Mr. Sylvain entered into an offer letter with the Company (the “Offer Letter”) providing for an annual base salary of $767,000 and annual target bonus opportunity equal to 75% of his base salary. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Dexcom in Readster

Add Dexcom to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.